Deferiprone market was valued at US$ 39.89 million in 2024 and is projected to hit the market valuation of US$ 55.22 million by 2033 at a CAGR of 3.68% during the forecast period 2025–2033.

Al Harith now dreams of becoming a radiology specialist. "I want to help patients, to be a reason for alleviating their pain, ...

Sickle cell anemia is a hereditary blood disorder resulting from mutations in genes responsible for hemoglobin formation. These mutations cause a change in the shape of red blood cells from round to ...

The Sickle Cell Disease Treatment Market is expected to reach at a CAGR of 15.8% during the forecast period 2025-2033. The Sickle Cell Disease Treatment Market is growing due to rising disease ...

Abnormal erythrocytes have diverse shapes. The appearance of specific erythrocyte shapes in a person's blood can indicate certain diseases, including thalassemia. We used thalassemia peripheral blood ...

How the cell and gene therapy market is taking shape Cell and gene therapy is poised to revolutionize the treatment of complex diseases, offering new possibilities for patients. However, for the ...

The two most common conditions identified were beta-thalassaemia trait (38.7%) and sickle cell disease (30%). Thalassemia. Beta-thalassaemia affects the body's ability to produce enough red blood ...

Sickle cell experts say the future of a critical data collection program is in flux after staff at the CDC's Division of Blood Disorders were placed on administrative leave without a clear future ...

The MCHC blood test measures the concentration of hemoglobin in red blood cells, helping diagnose anemia and other blood disorders.

Tharu tribals face higher rates of thalassemia (22-24%) and sickle cell anaemia (60%) than the general population, prompting a medical camp for 2 lakh people.